High prevalence of vitamin D deficiency in HIV-infected adults: what are the future research questions? (Q39673591)

13 September 2017

High prevalence of vitamin D deficiency in HIV-infected adults: what are the future research questions? (English)

1 reference

13 September 2017

0 references

0 references

0 references

1 reference

Temitope Oyedele

1

1 reference

PubMed ID

22187389

13 September 2017

Oluwatoyin M Adeyemi

series ordinal

2

1 reference

13 September 2017

1 March 2012

1 reference

13 September 2017

Current HIV/AIDS reports

1 reference

13 September 2017

9

1 reference

13 September 2017

1

1 reference

13 September 2017

1-4

1 reference

https://scigraph.springernature.com/pub.10.1007/s11904-011-0101-9

13 September 2017

0 references

cites work

Severe deficiency of 1,25-dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0101-9

Vitamin D status of HIV-infected women and its association with HIV disease progression, anemia, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0101-9

Hypovitaminosis D and bone mineral density in human immunodeficiency virus-infected men from India, with or without antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0101-9

Effect of bimonthly supplementation with oral cholecalciferol on serum 25-hydroxyvitamin D concentrations in HIV-infected children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0101-9

High frequency of vitamin D deficiency in ambulatory HIV-Positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0101-9

Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0101-9

Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0101-9

High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0101-9

Vitamin D deficiency in HIV-infected postmenopausal Hispanic and African-American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0101-9

Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0101-9

Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin D Levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population

21 January 2018

1 reference

12 December 2020

Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States

1 reference

12 December 2020

Vitamin D status in adolescents and young adults with HIV infection

1 reference

12 December 2020

Deficiency of 25-hydroxyvitamin D in male HIV-positive patients: A descriptive cross-sectional study

1 reference

12 December 2020

10.1007/S11904-011-0101-9

Identifiers

DOI

1 reference

13 September 2017

1 reference

PubMed ID

22187389